Navigation Links
How mitochondrial DNA defects cause inherited deafness
Date:2/17/2012

New Haven, Conn. Yale scientists have discovered the molecular pathway by which maternally inherited deafness appears to occur: Mitochondrial DNA mutations trigger a signaling cascade, resulting in programmed cell death. The study is in the Feb. 17 issue of Cell.

Mitochondria are cellular structures that function as "cellular power plants" because they generate most of the cell's supply of energy. They contain DNA inherited from one's mother. Mitochondria determine whether a cell lives or dies via the process of programmed cell death, or apoptosis.

The Yale scientists focused on a specific mitochondrial DNA mutation that causes maternally inherited deafness. The mutation occurs in a gene that codes for RNA in mitochondrial ribosomes, which generate proteins required for cellular respiration. The team found that cell lines containing this mutation are prone to cell death not directly due to the mutation, but rather because it enhanced a normal chemical modification of the RNA called methylation, which regulates ribosome assembly.

"Our lab had previously discovered that overexpression of the enzyme responsible for this methylation could cause cell death, even in cells without the deafness mutation," said corresponding author Gerald S. Shadel, professor of pathology and genetics at Yale School of Medicine. "But when the researchers overexpressed the enzyme in mice to mimic the effects of the mutation," he said, "we were astonished to discover that the animals progressively lost their hearing, reflecting how such disease would develop due to a known pathogenic human mitochondrial DNA mutation. This new mouse model will be instrumental in understanding genetic and environmental factors known to impact mitochondrial disease pathology."

The researchers found that reactive oxygen molecules produced by diseased mitochondria are what trigger events leading to a cell death-inducing gene expression program. By genetically dep
'/>"/>

Contact: Helen Dodson
helen.dodson@yale.edu
203-436-3984
Yale University
Source:Eurekalert

Page: 1 2

Related medicine news :

1. New mitochondrial control mechanism discovered
2. Animal results may pave way to treating rare mitochondrial diseases in children
3. Exposure to BPA may cause permanent fertility defects, Yale researchers find
4. Low blood oxygen may lead to heart defects in children with sickle cell disease
5. Many Non-U.S. Firms Affected by U.S. FDA Import Alert 80-04 for Medical Glove Manufacturing Defects, According to FDAImports.com, LLC
6. Psychotropic medications can cause birth defects
7. Experts Believe Many Birth Defects Are Preventable
8. Study implicates new epigenetic player in mental retardation and facial birth defects
9. Pediatric urologist performs innovative procedure for girls with rare vaginal defects
10. Growth defects in cystic fibrosis may start before birth
11. Doubled risk of anxiety for 18 month-old children with congenital heart defects
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... For many busy people, having their missing or ... of recovery from dental surgery that have traditionally been required ... of their youthful appearance. , But the dental implant ... and Woodland Hills, Calif., can provide someone with a full ... where the patient’s bone has deteriorated. , Dr. Saj Jivraj ...
(Date:11/21/2014)... OR (PRWEB) November 21, 2014 Even with ... always something to learn and room for growth, participating in ... returned from State Farm’s National Convention, a networking event with ... around the country, bringing back the latest and greatest in ... may have spotted Kirk and his team (Stacy, Anthony, Reina ...
(Date:11/21/2014)... West Palm Beach, FL (PRWEB) November 21, 2014 ... Administration report issued on June 11th, 2014, ... Takata Corporation can rupture when the airbag inflates. The ... break into metal shrapnel, and the metal shards may ... anyone within the vehicle’s cabin. , According to ...
(Date:11/21/2014)... HealthDay Reporter THURSDAY, Nov. 20, ... may help preserve thinking skills and memory as workers ... compared IQ scores obtained around age 11 from more ... scores around age 70. The scientists found that those ... thinking even years after retirement. Researchers from ...
(Date:11/21/2014)... 20, 2014 (HealthDay News) -- While levels of testosterone ... women,s sex lives, their emotional health and quality of ... new study. Testosterone is the main sex hormone ... amounts of the hormone, the researchers noted. The ... taking part in a long-term study of women,s health. ...
Breaking Medicine News(10 mins):Health News:Anacapa Dental Art Institute Prosthodontists Develop New Technique to Offer Younger Appearance in Just One Visit 2Health News:Anacapa Dental Art Institute Prosthodontists Develop New Technique to Offer Younger Appearance in Just One Visit 3Health News:Anacapa Dental Art Institute Prosthodontists Develop New Technique to Offer Younger Appearance in Just One Visit 4Health News:Anacapa Dental Art Institute Prosthodontists Develop New Technique to Offer Younger Appearance in Just One Visit 5Health News:Kirk Martin Insurance Agency Goes Local and National with State Farm 2Health News:Takata Airbag Recall Class Action Lawsuit Resource Released by Florida Injury Attorney 2Health News:Takata Airbag Recall Class Action Lawsuit Resource Released by Florida Injury Attorney 3Health News:Could Your Job Help Preserve Your Aging Brain? 2Health News:Could Your Job Help Preserve Your Aging Brain? 3Health News:Testosterone Plays Minor Role in Older Women's Sex Lives, Study Finds 2
... , , SAN FRANCISCO, July 31 ... announced the execution of a letter of intent (LOI) to collaborate ... diagnostic testing and banking of advanced-stage Lung Cancer tissues. ... ) , , Specific molecular features ...
... times more likely to have chronic health conditions, less ... lower incomes than their siblings, according to a study ... the National Cancer Institute . This study was ... for neuroblastoma survivors. Caroline Laverdiere, M.D., of the ...
... , TITUSVILLE, N.J., July 31 The ... palmitate) extended-release injectable suspension for the acute and maintenance treatment ... injectable atypical antipsychotic approved in the U.S. for this use. ... in the U.S. , , An estimated ...
... health conditions are spread, study finds , FRIDAY, July 31 ... surgery doesn,t appear to increase one,s chances of having long-term ... study of 1,062 people who required a transfusion before, during ... of the patients were still alive a decade after the ...
... , GAINESVILLE, Fla., July 31 ... correction of facial wrinkles in healthy patients in the USA. It ... Surgeon, has 7 years of experience with the product while abroad. ... , Sanofi-aventis is a leading global pharmaceutical company. The ...
... 31 In a post-recession America, even though as a nation income ... crushing burden of health care costs and will watch their standards of ... the New England Journal of Medicine (NEJM) by Daniel ... University of Pennsylvania,s Leonard Davis Institute of Health Economics. , ...
Cached Medicine News:Health News:Addario Lung Cancer Medical Institute Announces Diagnostic Screening and Clinical Research Collaborations With Response Genetics, Inc. 2Health News:Addario Lung Cancer Medical Institute Announces Diagnostic Screening and Clinical Research Collaborations With Response Genetics, Inc. 3Health News:Addario Lung Cancer Medical Institute Announces Diagnostic Screening and Clinical Research Collaborations With Response Genetics, Inc. 4Health News:Long-term health and social outcomes for neuroblastoma survivors 2Health News:FDA Approves INVEGA(R) SUSTENNA(TM) for the Acute and Maintenance Treatment of Schizophrenia 2Health News:FDA Approves INVEGA(R) SUSTENNA(TM) for the Acute and Maintenance Treatment of Schizophrenia 3Health News:FDA Approves INVEGA(R) SUSTENNA(TM) for the Acute and Maintenance Treatment of Schizophrenia 4Health News:FDA Approves INVEGA(R) SUSTENNA(TM) for the Acute and Maintenance Treatment of Schizophrenia 5Health News:FDA Approves INVEGA(R) SUSTENNA(TM) for the Acute and Maintenance Treatment of Schizophrenia 6Health News:FDA Approves INVEGA(R) SUSTENNA(TM) for the Acute and Maintenance Treatment of Schizophrenia 7Health News:FDA Approves INVEGA(R) SUSTENNA(TM) for the Acute and Maintenance Treatment of Schizophrenia 8Health News:FDA Approves INVEGA(R) SUSTENNA(TM) for the Acute and Maintenance Treatment of Schizophrenia 9Health News:Post-Recession Incomes Will Be Hit Hard by Health Care Spending for Middle Class Working Families, PENN Analysis Shows 2Health News:Post-Recession Incomes Will Be Hit Hard by Health Care Spending for Middle Class Working Families, PENN Analysis Shows 3Health News:Post-Recession Incomes Will Be Hit Hard by Health Care Spending for Middle Class Working Families, PENN Analysis Shows 4
(Date:11/21/2014)... NEW YORK , Nov. 20, 2014  Market research ... as the "Year of The Buy, in the medical ... market for medical devices will produce just 3% growth ... competitive actions, including acquisitions of product lines and entrance ... an annual survey of medical devices, The Global ...
(Date:11/21/2014)... QC , Nov. 20, 2014 /CNW Telbec/ - ... to announce the following appointments: ... team in the newly created role of Chief Commercial ... BioPhotonic system using topical photoconverter gel for the treatment ... surgical and traumatic wounds, recently approved in ...
(Date:11/21/2014)... Calif. , Nov. 20, 2014 Depomed, Inc. (NASDAQ: ... at the Piper Jaffray 26 th Annual Healthcare Conference in ... at the Piper Jaffray conference is scheduled for 8:00 am EST ... be webcast, and the webcast can be accessed via the Investor ... recording of the webcast will be archived for 30 days on ...
Breaking Medicine Technology:Kalorama: 2014 The "Year of The Buy" in Medical Device Industry 2KLOX Technologies announces executive appointments 2KLOX Technologies announces executive appointments 3KLOX Technologies announces executive appointments 4Depomed To Present At Piper Jaffray 26th Annual Healthcare Conference 2
... DIEGO, May 12, 2011 GT Life Sciences, Inc., ... issuance of Patent No. 7,856,317 for "SYSTEMS AND METHODS ... Patent and Trademark Office.  The ,317 patent has a ... novel claims to computer systems and complex modeling processes ...
... Reportlinker.com announces that a new ... its catalogue: Generic ... Focus on Super Generics and Biosimilars ... http://www.reportlinker.com/p0491876/Generic-Growth-Strategies---Manufacturers-to-Increase-Focus-on-Super-Generics-and-Biosimilars-to-Drive-Revenues.html?utm_source=prnewswire&utm_medium=pr&utm_campaign=Vitamin_and_Supplement Generic ...
Cached Medicine Technology:GT Life Sciences Broadens Intellectual Property Portfolio with Issuance of U.S. Patent on Core Computational Systems and Methods for Genomic-based Metabolic Modeling 2GT Life Sciences Broadens Intellectual Property Portfolio with Issuance of U.S. Patent on Core Computational Systems and Methods for Genomic-based Metabolic Modeling 3Reportlinker Adds Generic Growth Strategies - Manufacturers to Increase Focus on Super Generics and Biosimilars to Drive Revenues 2Reportlinker Adds Generic Growth Strategies - Manufacturers to Increase Focus on Super Generics and Biosimilars to Drive Revenues 3Reportlinker Adds Generic Growth Strategies - Manufacturers to Increase Focus on Super Generics and Biosimilars to Drive Revenues 4Reportlinker Adds Generic Growth Strategies - Manufacturers to Increase Focus on Super Generics and Biosimilars to Drive Revenues 5Reportlinker Adds Generic Growth Strategies - Manufacturers to Increase Focus on Super Generics and Biosimilars to Drive Revenues 6Reportlinker Adds Generic Growth Strategies - Manufacturers to Increase Focus on Super Generics and Biosimilars to Drive Revenues 7
Due to its thick formula, REFRESH CELLUVISC Lubricant Eye Drops is ideal for persistent dry eye conditions. REFRESH CELLUVISC provides lasting relief and protection for dry, scratchy eyes....
... solution is an anti-infective prescription ... may instruct you to use ... infection caused by bacteria. Bacterial ... the 2 types of eye ...
ALPHAGAN® (brimonidine tartrate ophthalmic solution) 0.2% is indicated for lowering IOP in patients with open-angle galucoma or ocular hypertension....
ALPHAGAN® (brimonidine tartrate ophthalmic solution) 0.2% is indicated for lowering IOP in patients with open-angle galucoma or ocular hypertension....
Medicine Products: